Could BRAF inhibition be a viable neoadjuvant strategy?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • Findings of a recent study suggest that BRAF inhibition may be effective as a neoadjuvant therapy in patients with advanced locoregional BRAF V600E mutant melanoma.

Study Design

  • Analysis of outcomes in patients with locoregional BRAF V600E-mutant melanoma...